Concepedia

Rohit Srivastava

RS

Statistics

Publications

34

Citations

1.4K

H-Index

21

Active since

1979

Affiliations

Central Drug Research Institute(Current)

Indian Institute of Technology Bombay

University of Kansas Medical Center

University of Maryland, Baltimore

University of Lucknow

Rohit Srivastava is an author at Central Drug Research Institute specializing in medicine, engineering, and biomedical engineering.

ORCID

Top concepts

Publications per year

1979–2022

34

Publications

34

Multifunctional gold coated thermo-sensitive liposomes for multimodal imaging and photo-thermal therapy of breast cancer cells

Aravind Kumar Rengan, Madhura Jagtap, Abhijit De et al. · Nanoscale · 2013 · 152 citations

, , +14

NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200

Junsheng Fu, Marianna Rodova, Rajesh Nanta et al. · Neuro-Oncology · 2013 · 105 citations · Full text

NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128

Rajesh Nanta, Dhruv Kumar, Daniel G. Meeker et al. · Oncogenesis · 2013 · 103 citations · Full text

, , +20

Evaluation of the LMA Supreme <sup>™</sup> in 100 non‐paralysed patients*

Tim Cook, J. J. Gatward, J Handel et al. · Anaesthesia · 2009 · 90 citations

Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa

Shilpa Rani Shankar, Rohit Srivastava · Carcinogenesis · 2007 · 90 citations · Full text

1–5 of 34